Orthofix Medical Inc. (OFIX)

AYAL Capital Advisors Ltd grew its holdings in shares of Orthofix Medical Inc. (NASDAQ: OFIX) by 74.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 943,203 shares of the medical device company's stock after acquiring an additional 403,433

Orthofix Medical Inc. ( OFIX ) UBS Global Healthcare Conference 2025 November 11, 2025 1:15 PM EST Company Participants Massimo Calafiore - President, CEO & Director Julie Dewey - Chief Investor Relations & Communications Officer Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division All right. Good afternoon, everyone.

Orthofix Medical Inc. ( OFIX ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Julie Dewey - Chief Investor Relations & Communications Officer Massimo Calafiore - President, CEO & Director Julie Andrews - Chief Financial Officer Conference Call Participants Thomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division Presentation Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today.

Orthofix (OFIX) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.07 per share a year ago.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6™ product lines. Highlights Third quarter.

Orthofix Medical Inc. (NASDAQ: OFIX - Get Free Report) has earned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: UBS Global Healthcare Conference in Palm Beach Gardens, FL, November 11, 2025, at 1:15 pm Eastern Time Stifel Healthcare Conference in New York, NY, November 12, 2025, at 10:00 am Eastern Time Jefferies.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referenci.

Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or Orthofix (OFIX). But which of these two stocks offers value investors a better bang for their buck right now?

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Orthofix (OFIX) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in  Orthofix between October 11, 2022, and September 12, 2023 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

Investors interested in Medical - Instruments stocks are likely familiar with Fresenius (FMS) and Orthofix (OFIX). But which of these two stocks presents investors with the better value opportunity right now?

Orthofix (OFIX) Q2 Revenue Rises 2%

Orthofix Medical Inc. (NASDAQ:OFIX ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Julie B. Andrews - Chief Financial Officer Julie D.

Orthofix (OFIX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.05 per share a year ago.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6® product lines. Highlights Second quarter 2025 net sales of $203.1 million, including sales from M6® artificial cervical and l.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix Investor Relations Website at ir.or.